Date: 27 February 2024
Time: To be announced
Duration: 3 days
Location: ExCeL London, Royal Victoria Dock, UK
Cost: Register online for more information.
Organiser: Hanson Wade
The cell therapy revolution over the last decade has been game-changing for cancer care, with CAR-T therapies now moving to 2nd line treatment for indications including diffuse large B-cell lymphoma.
However, challenges remain in harder to treat tumours with relapse rates high and durability low. Furthermore funding constraints mean it is critical to develop more potent, persistent, and targeted treatments with streamlined manufacturing and analytical processes to develop cost-effective and accessible therapies.
Without innovation, the field cannot progress. Which is why the 7th CAR-TCR Summit Europe is your must-attend meeting to gain a clear snapshot of the novel advances across preclinical, clinical and manufacturing pipelines to ensure your company stays ahead of the curve in this extremely competitive space.